Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT

Bone Marrow Transplantation

Volumn 45, Issue 4, 2010, Pages 705-711

  Boer, C C ^a   Correa, M E P ^a   Miranda, E C M ^a   De Souza, C A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Allogeneic HSCT; Oral health; Taste disorders

Indexed keywords

CAFFEINE; CITRIC ACID; CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SODIUM CHLORIDE; SUCROSE;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BITTER TASTE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL EVALUATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DYSPHAGIA; FEMALE; FLAVOR; HUMAN; HYPOSALIVATION; MAJOR CLINICAL STUDY; MALE; MASTICATION; MOUTH EXAMINATION; MOUTH PAIN; NAUSEA; PATIENT CODING; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVARY GLAND FUNCTION; SPEECH DISORDER; SWEETNESS; TASTE ACUITY; TASTE DISCRIMINATION; TASTE DISORDER; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; DYSGEUSIA; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TASTE THRESHOLD; XEROSTOMIA; YOUNG ADULT;

EID: 77950626845     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.237     Document Type: Article

References (26)

1. Kim UK, Breslin PA, Reed D, Drayna D. Genetics of human taste perception. J Dent Res 2004; 83: 448-453.
2. Kinnamon SC, Margolskee RF. Mechanisms of taste transduction. Curr Opin Neurobiol 1996; 6: 506-513.
3. Berteretche MV, Dalix AM, d'Ornano AM, Bellisle F, Khayat D, Faurion A. Decreased taste sensitivity in cancer patients under chemotherapy. Support Care Cancer 2004; 12: 571-576.
4. Comeau TB, Epstein JB, Migas C. Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer 2001; 9: 575-580.
5. Sherry VW. Taste alterations among patients with cancer. Clin J Oncol Nurs 2002; 6: 73-77.
6. Wickham RS, Rehwaldt M, Kefer C, Shott S, Abbas K, Glynn-Tucker E et al. Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum 1999; 26: 697-706.
7. Imanguli MM, Pavletic SZ, Guadagnini JP, Brahim JS, Atkinson JC. Chronic graft versus host disease of oral mucosa: review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 175-183.
8. Nakamura S, Hiroki A, Shinohara M, Gondo H, Ohyama Y, Mouri T et al. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 556-563.
9. Nagler RM, Nagler A. The molecular basis of salivary gland involvement in graft-vs.-host disease. J Dent Res 2004; 83: 98-103.
10. Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003; 101: 3373-3385.
11. Avsar A, Elli M, Darka O, Pinarli G. Long-term effects of chemotherapy on caries formation, dental development, and salivary factors in childhood cancer survivors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: 781-789.
12. Schubert MM, Sullivan KM, Morton TH, Izutsu KT, Peterson DE, Flournoy N et al. Oral manifestations of chronic graft-v-host disease. Arch Intern Med 1984; 144: 1591-1595.
13. Hiroki A, Nakamura S, Shinohara M, Oka M. Significance of oral examination in chronic graft-versus-host disease. J Oral Pathol Med 1994; 23: 209-215.
14. Mattsson T, Arvidson K, Heimdahl A, Ljungman P, Dahllof G, Ringden O. Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med 1992; 21: 33-37.
15. Flink H, Tegelberg A, Lagerlof F. Influence of the time of measurement of unstimulated human whole saliva on the diagnosis of hyposalivation. Arch Oral Biol 2005; 50: 553-559. (Pubitemid 40560959)
16. Marinone MG, Rizzoni D, Ferremi P, Rossi G, Izzi T, Brusotti C. Late taste disorders in bone marrow transplantation: clinical evaluation with taste solutions in autologous and allogeneic bone marrow recipients. Haematologica 1991; 76: 519-522.
17. Schiffman SS, Gatlin CA. Clinical physiology of taste and smell. Annu Rev Nutr 1993; 13: 405-436.
18. Ripamonti C, Fulfaro F. Taste alterations in cancer patients. J Pain Symptom Manage 1998; 16: 349-351.
19. Gallagher P, Tweedle DE. Taste threshold and acceptability of commercial diets in cancer patients. JPEN J Parenter Enteral Nutr 1983; 7: 361-363. (Pubitemid 13069642)
20. Ravasco P. Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs 2005; 9(Suppl 2): S84-S91. (Pubitemid 41488131)
21. Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002; 30: 785-792. (Pubitemid 36004307)
22. Coracin FL, Pizzigatti Correa ME, Camargo EE, Peterson DE, de Oliveira Santos A, Vigorito AC et al. Major salivary gland damage in allogeneic hematopoietic progenitor cell transplantation assessed by scintigraphic methods. Bone Marrow Transplant 2006; 37: 955-959.
23. Rhodes VA, McDaniel RW, Hanson B, Markway E, Johnson M. Sensory perception of patients on selected antineoplastic chemotherapy protocols. Cancer Nurs 1994; 17: 45-51. (Pubitemid 24080588)
24. DeWys WD, Walters K. Abnormalities of taste sensation in cancer patients. Cancer 1975; 36: 1888-1896.
25. Murray SM, Pindoria S. Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev 2009; 5: Art no. CD002920.
26. Deeg HJ, Seidel K, Bruemmer B, Pepe MS, Appelbaum FR. Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant 1995; 15: 461-468.